Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis (Q39674948)

From Wikidata

Jump to navigation Jump to search

scientific article published on 17 June 2016

Language	Label	Description	Also known as
English	Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis	scientific article published on 17 June 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis (English)

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

stem cell transplantation

1 reference

based on heuristic

inferred from title

Robert Peter Gale

13

object named as

Robert Peter Gale

1 reference

Europe PubMed Central

5 October 2017

PMC publication ID

Martin Bornhäuser

8

object named as

Martin Bornhauser

1 reference

Europe PubMed Central

5 October 2017

PMC publication ID

Hillard M. Lazarus

20

object named as

Hillard M Lazarus

1 reference

Europe PubMed Central

5 October 2017

PMC publication ID

Brenda M Sandmaier

41

object named as

Brenda M Sandmaier

1 reference

Europe PubMed Central

5 October 2017

PMC publication ID

30

object named as

Harry C Schouten

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

22

object named as

Mark R Litzow

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Peter H. Wiernik

35

object named as

Peter H Wiernik

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Jane L. Liesveld

21

object named as

Jane Liesveld

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

37

object named as

Ann E Woolfrey

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

33

object named as

Geoffrey L Uy

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Steven M Devine

39

object named as

Steven Devine

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

15

object named as

Mehdi Hamadani

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

44

object named as

Wael Saber

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

3

object named as

Kwang Woo Ahn

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Rammurti T Kamble

18

object named as

Rammurti Kamble

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

36

object named as

Baldeep Wirk

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

28

object named as

Ayman A Saad

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Taiga Nishihori

24

object named as

Taiga Nishihori

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Mitchell Sabloff

29

object named as

Mitchell Sabloff

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

5

object named as

Mahmoud Aljurf

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Siddhartha Ganguly

14

object named as

Siddhartha Ganguly

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

19

object named as

John Koreth

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

38

object named as

Donald Bunjes

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Yoshihiro Inamoto

16

object named as

Yoshihiro Inamoto

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

26

object named as

Ran Reshef

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Bruce M Camitta

10

object named as

Bruce Camitta

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

12

object named as

Corey S Cutler

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

9

object named as

Jean-Yves Cahn

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Minoo Battiwalla

7

object named as

Minoo Battiwalla

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Robert J Soiffer

32

object named as

Robert J Soiffer

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

1

object named as

Abhinav Deol

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

author name string

Salyka Sengsayadeth

2

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Hai-Lin Wang

4

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Joseph Harry Antin

6

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Yi-Bin Chen

11

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Madan Jagasia

17

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

David I Marks

23

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Richard F Olsson

25

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Jacob M Rowe

27

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Thomas C Shea

31

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Edmond K Waller

34

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Marcos de Lima

40

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Dan Weisdorf

42

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Hanna Jean Khoury

43

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

language of work or name

0 references

publication date

17 June 2016

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

122

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

19

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

3005-3014

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5030151

15 June 2018

Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5030151

15 June 2018

FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5030151

15 June 2018

Differential impact of allelic ratio and insertion site in FLT3-ITD-positive AML with respect to allogeneic transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5030151

15 June 2018

Phase I trial of maintenance sorafenib after allogeneic hematopoietic stem cell transplantation for fms-like tyrosine kinase 3 internal tandem duplication acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5030151

15 June 2018

FLT3 mutations in acute myeloid leukemia: what is the best approach in 2013?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5030151

15 June 2018

FLT3/ITD AML and the law of unintended consequences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5030151

15 June 2018

Role of Allogeneic Transplantation for FLT3/ITD Acute Myeloid Leukemia: Outcomes from 133 Consecutive Newly Diagnosed Patients from a Single Institution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5030151

15 June 2018

Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5030151

15 June 2018

Defining the intensity of conditioning regimens: working definitions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5030151

15 June 2018

Outcome of patients with FLT3-mutated acute myeloid leukemia in first relapse

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5030151

15 June 2018

Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5030151

15 June 2018

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5030151

15 June 2018

Prognostic relevance of FLT3-TKD mutations in AML: the combination matters--an analysis of 3082 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5030151

15 June 2018

No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5030151

15 June 2018

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5030151

15 June 2018

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5030151

15 June 2018

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5030151

15 June 2018

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5030151

15 June 2018

FLT3: ITDoes matter in leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5030151

17 June 2018

Sorafenib treatment following hematopoietic stem cell transplant in pediatric FLT3/ITD acute myeloid leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5030151

21 August 2018

Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5030151

21 August 2018

Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a retrospective analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5030151

21 August 2018

How I treat acute myeloid leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5030151

21 August 2018

Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5030151

21 August 2018

Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the Flt3 gene

1 reference

https://api.crossref.org/works/10.1002/CNCR.30140

7 January 2021

based on heuristic

inferred from DOI database lookup

FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002/CNCR.30140

7 January 2021

based on heuristic

inferred from DOI database lookup

The preferential occurrence of FLT3-TKD mutations in inv(16) AML and impact on survival outcome: a combined analysis of 1053 core-binding factor AML patients

1 reference

https://api.crossref.org/works/10.1002/CNCR.30140

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplantation in AML CR1

1 reference

https://api.crossref.org/works/10.1002/CNCR.30140

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved outcome after stem-cell transplantation in FLT3/ITD-positive AML

1 reference

https://api.crossref.org/works/10.1002/CNCR.30140

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of allogeneic stem cell transplantation in FLT3/ITD-positive AML

1 reference

https://api.crossref.org/works/10.1002/CNCR.30140

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27315441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of a phase 1 study of quizartinib as maintenance therapy in subjects with acute myeloid leukemia in remission following allogeneic hematopoietic stem cell transplant.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27315441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Internal tandem duplication of the flt3 gene found in acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27315441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CNCR.30140

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

5 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39674948&oldid=1858006887"